LIVE TV
ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Budget 2021
  • Personal Finance
    • PPF
    • Mutual Funds
    • Income tax
    • EPFO
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
    • SIP calculator
    • SWP Calculator
    • MF Returns Calculator
    • Lumpsum Calculator
  • India
    • Companies
    • Property
    • Startups
    • Uidai
  • Economy
    • Aviation
  • Tech
    • Mobiles
    • Apps
  • Auto
    • Cars
    • Bikes
  • Markets
    • Commodities
    • Currency
  • Jobs
  • Indian Railways
  • World
    • Economy
    • Politics
    • Markets
  • videos
  • photos
  • Authors
  • More ...
    • VIDEOS
    • PHOTOS
Business News » Companies News

Divi's Laboratories report 9% rise in net profit in Q3

Updating on US-FDA inspection, Divi's Lab said, "It has filed its comprehensive response to the observations of the FDA regulator within the stipulated time. Now it awaits for review from the US pharma regulator. 

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
Divi's Laboratories report 9% rise in net profit in Q3
During the nine month period, Divi's Lab has capitalized assets of Rs 180 crore for creation of additional capacities at the existing manufacturing sites. Photo: Official Website
Written By: ZeeBiz WebTeam
Updated: Sat, Feb 04, 2017
12:43 pm
Mumbai, ZeeBiz WebDesk
RELATED NEWS
Divi's Lab Share price: Anand Rathi positive, says BUY, target price Rs 4095 | Here is what you need to know Divi's Lab Share price: Anand Rathi positive, says BUY, target price Rs 4095 | Here is what you need to know
Divi's laboratories drops over 10% on USFDA reports Divi's laboratories drops over 10% on USFDA reports

Divi's Laboratories on Saturday reported standalone net profit of Rs 268.32 crore for its third quarter ended December 31, 2016, registering a growth of 8.73% from Rs 246.76 crore in the corresponding period of the previous year. 

Total income from operations stood at Rs 976.48 crore, which was up by 13.57% year-on-year (YoY) but down by 2.87% quarter-on-quarter (QoQ) basis. 

During the nine month period, Divi's Lab has capitalized assets of Rs 180 crore for creation of additional capacities at the existing manufacturing sites. 

Till end of period, an amount of Rs 400 crore is carried forward as capital expenditure in progress. 

Updating on US-FDA inspection, Divi's Lab said, "It has filed its comprehensive response to the observations of the FDA regulator within the stipulated time. Now it awaits for review from the US pharma regulator. 

Divi's Lab had an inspection in one of its unit by the US-FDA from November 29, 2016 - December 06, 2016. It had received Form-483 with observation at the closure of the inspection."

For the current quarter, forex gain amounted to Rs 0.65 crore, compared to the gains of Rs 3 crore a year ago same period. 

On Friday shares of Divi's Lab closed at Rs 759.80 per share on BSE, surging over Rs 21.90 or 2.97%. 

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Divis LaboratoryDivis Lab q3 resultQ3FY17financial performanceforex gainUSFDA inspectionpharmaceuticalMarketBSEShares
RELATED NEWS
Divi's Lab Share price: Anand Rathi positive, says BUY, target price Rs 4095 | Here is what you need to know Divi's Lab Share price: Anand Rathi positive, says BUY, target price Rs 4095 | Here is what you need to know
Divi's laboratories drops over 10% on USFDA reports Divi's laboratories drops over 10% on USFDA reports

LATEST NEWS

PUBG Mobile India launch tomorrow? Check trailer and other reports and latest updates

Master Box Office Collection: Superb numbers! Thalapathy Vijay vs Makkal Selvan Vijay Sethupathi movie braves pandemic

Double for Stones as Manchester City crush Crystal Palace to go second

Adani Green, Metal Stocks, NBFC Stocks to FMCG stocks - here are top Buzzing Stocks today

IRFC IPO Review: ICICI Securities on Indian Railway Finance Corporation issue

Income Tax Refund Status: Yet to get credit after seven days of ITR filing? Check for these common mistakes

IRFC IPO Review: Price band, asset quality, valuation, ownership, growth, sources to funding to business model - know Key Investment Rationale by IDBI Capital

Stocks to buy with Anil Singhvi: MSTC in Cash and IDFC First Bank in F & O space, Here are Vikas Sethi’s top two picks for good returns

IRFC IPO Review: Anil Singhvi says IRFC shares will yield better returns than FDs - Details inside

Maharashtra Gram Panchayat Election Results 2021 Live Update: Counting is on - Check latest news, BJP, NCP, Congress, Shiv Sena seats here

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
Copyright © Zee Media Corporation Ltd. All rights reserved